You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atll

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

Recruiting
  • Adult T-cell Leukemia-Lymphoma
  • ATLL
  • Miami, Florida
    University of Miami
Jan 24, 2022

Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

Active, not recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
  • Yamagata, Japan
    Yamagata University Hospital
Feb 21, 2022

Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

Completed
  • Cutaneous T-cell Lymphoma (CTCL)
  • +4 more
  • Duarte, California
  • +18 more
Nov 19, 2020

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
Nov 30, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

Not yet recruiting
  • T Cell Lymphoma
  • New Haven, Connecticut
    Yale Smilow Cancer Hospital
Aug 14, 2023

Leukemia/Lymphoma Trial in Milwaukee

Active, not recruiting
  • Leukemia/Lymphoma
    • Milwaukee, Wisconsin
      CIBMTR
    Nov 17, 2021

    Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Pediatric Hodgkin Lymphoma
    • Brentuximab Vedotin (Genetical Recombination)
    • Tokyo, Japan
      Takeda Selected Site
    Oct 11, 2022

    Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

    Not yet recruiting
    • Adult T-cell Leukemia/Lymphoma
    • +4 more
    • CC-486 (5-azacitidine)
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Adult T-cell Leukemia-Lymphoma, Peripheral T-cell Lymphoma Trial in Japan (Lenalidomide)

    Completed
    • Adult T-cell Leukemia-Lymphoma
    • Peripheral T-cell Lymphoma
    • Fukuoka, Japan
    • +5 more
    Nov 6, 2019

    Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

    Completed
    Has Results
    • Acute Adult T-Cell Leukemia/Lymphoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Baltimore, Maryland
    • +7 more
    Dec 2, 2019

    HTLV-I Infections Trial in Belém (Rehabilitation)

    Completed
    • HTLV-I Infections
    • Rehabilitation
    • Belém, Pará, Brazil
      Universidade da Amazônia
    Aug 11, 2020

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +4 more
    • Atlanta, Georgia
    • +2 more
    Jul 25, 2018

    Tropical Spastic Paraparesis, HTLV-1 Trial in Salvador (Urological physical therapy)

    Completed
    • Tropical Spastic Paraparesis
    • HTLV-1
    • Urological physical therapy
    • Salvador, Bahia, Brazil
      Hospital Universitário Prof. Edgard Santos
    Oct 3, 2018

    Prospective Collection of Data in Peripheral T-Cell Lymphoma

    Completed
    • Lymphoma, T-Cell, Peripheral
      • Palo Alto, California
      • +75 more
      Jul 3, 2019

      Adult T-cell Leukemia, Lymphoma Trial in Nagasaki (VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis, biweekly-CHOP with

      Completed
      • Adult T-cell Leukemia
      • Lymphoma
      • VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis
      • biweekly-CHOP with G-CSF and intrathecal prophylaxis
      • Nagasaki, Japan
        Nagasaki University Graduate School of Biomedical Science
      Sep 20, 2016

      Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)

      Completed
      Has Results
      • Hodgkin Lymphoma
      • Non-Hodgkin Lymphoma
      • Camidanlumab tesirine
      • Duarte, California
      • +11 more
      Jul 12, 2021

      Adult T-Cell Leukemia-Lymphoma Trial in Japan (Lenalidomide)

      Completed
      Has Results
      • Adult T-Cell Leukemia-Lymphoma
      • Nagoya, Aichi, Japan
      • +17 more
      Mar 18, 2018

      Lymphoma, Precancerous/Nonmalignant Condition Trial in Miami (PEG-interferon alfa-2b, Interferon alfa-2b, Valproic Acid)

      Terminated
      Has Results
      • Lymphoma
      • Precancerous/Nonmalignant Condition
      • PEG-interferon alfa-2b
      • +3 more
      • Miami, Florida
        University of Miami Sylvester Comprehensive Cancer Center - Miam
      Mar 19, 2018

      Leukemia-Lymphoma, Adult T-Cell Trial in United States (Bortezomib, Etoposide, Vincristine)

      Completed
      Has Results
      • Leukemia-Lymphoma, Adult T-Cell
      • Miami, Florida
      • +5 more
      Feb 8, 2017

      Peripheral T Cell Lymphoma Trial in Guangzhou (chidamide, cyclophosphamide, liposomal doxorubicin)

      Unknown status
      • Peripheral T Cell Lymphoma
      • Guangzhou, Guangdong, China
        Ru Feng
      Jan 13, 2017

      Adult T Cell Leukemia/Lymphoma Trial in New York (Lenalidomide)

      Completed
      Has Results
      • Adult T Cell Leukemia/Lymphoma
      • New York, New York
        Columbia University Medical Center
      Apr 21, 2016

      HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Trial in London (CHOP-daclizumab)

      Completed
      • HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
      • London, United Kingdom
        King's College Hospital NHS Foundation Trust
      Aug 19, 2011